Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Insmed Incorporated - Common Stock (NQ:INSM)

102.15 -2.77 (-2.64%)

Streaming Delayed Price Updated: 9:42 AM EDT, Jun 5, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	99,111
Open	103.78
Bid (Size)	101.54 (100)
Ask (Size)	102.76 (500)
Prev. Close	104.92
Today's Range	101.00 - 105.00
52wk Range	70.57 - 212.75
Shares Outstanding	115,246,666
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

NWI Management Dumps 42,700 MercadoLibre Shares Worth $82.4 Million ↗

May 30, 2026

MercadoLibre delivers e-commerce and fintech solutions across Latin America, leveraging an integrated digital ecosystem for regional growth.

Via The Motley Fool

Why This Fund Made a $189 Million Bet on Erasca as Shares Skyrocket 800% ↗

May 29, 2026

This clinical-stage biotech develops targeted oral therapies for RAS/MAPK-driven cancers, with all assets currently in development.

Via The Motley Fool

Performance

YTD	-42.3%	-42.3%
1 Month	-26.7%	-26.7%
3 Month	-28.9%	-28.9%
6 Month	-50.2%	-50.2%
1 Year	+38.6%	+38.6%

More News

Tango Therapeutics Stock Is Up 840%, and This Fund Just Disclosed Buying $164 Million More ↗

May 29, 2026

Via The Motley Fool

Insmed (NASDAQ:INSM) Q1 Revenue Miss Triggers Pre-Market Slide Despite Narrower Loss ↗

May 07, 2026

Via Chartmill

Investment Firm Closes Out Entire $18.1 Million Position in Biotech Stock, According to Latest SEC Filing ↗

May 26, 2026

Via The Motley Fool

Insmed CEO Defends BRINSUPRI Launch as Sales Surge, TPIP Pipeline Gains Focus ↗

May 18, 2026

Via MarketBeat

Patient Square Makes a Big Bet on Nektar Pharmaceuticals (NKTR) Purchasing 210,000 Shares ↗

May 16, 2026

Via The Motley Fool

This Nuclear Tech Stock Grew Revenue 27%, But a Fund Still Slashed Its Stake ↗

May 15, 2026

Via The Motley Fool

This Retail Stock Is Down 10% in a Year Despite Record Revenue. A Fund Just Cut Its Stake ↗

May 15, 2026

Via The Motley Fool

This Trade School Stock Is Up 135%. Here’s Why a Fund Still Bought 459,000 Shares ↗

May 15, 2026

Via The Motley Fool

Callaway Stock Has Soared 150%. Here’s Why One Fund Still Bought 1.1 Million Shares ↗

May 15, 2026

Via The Motley Fool

Insmed (INSM) Q1 2026 Earnings Transcript ↗

May 07, 2026

Via The Motley Fool

This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround Story ↗

March 21, 2026

Via The Motley Fool

This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug Launch ↗

March 21, 2026

Via The Motley Fool

This Specialized Heart Monitor Maker Just Caught the Eye of a Major Healthcare Fund ↗

March 20, 2026

Via The Motley Fool

This $91 Million Position Signals Conviction in a Biotech Stock Eyeing FDA Decision This Year ↗

March 20, 2026

Via The Motley Fool

The Small-Cap Renaissance: Why the Russell 2000 is Leading the Charge in 2026

March 09, 2026

Via MarketMinute

Investment Manager Bets Big on PTCT Stock, Adds 41,000 Shares, According to Recent SEC Filing ↗

March 03, 2026

Via The Motley Fool

Investment Firm Adds Nearly $4 Milllion Worth of DYN Shares, According to Recent SEC Filing ↗

March 02, 2026

Via The Motley Fool

Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing ↗

March 02, 2026

Via The Motley Fool

Investor Buys Up $81 Million in Praxis Stock as Shares Soar Over 300% in One Year ↗

February 23, 2026

Via The Motley Fool

This Fund Bet Nearly $40 Million on GRAIL Last Quarter. The Stock Just Plunged Over 50% ↗

February 23, 2026

Via The Motley Fool

Insmed (INSM) Q4 2025 Earnings Call Transcript ↗

February 19, 2026

Via The Motley Fool

Biotech Exit: $26 Million Arcellx Sale Follows Tepid Stock Performance and Kelonia Competition ↗

February 17, 2026

Via The Motley Fool

Cogent Biosciences Stock Up 346% as Fund Builds $29 Million Stake After November Phase 3 Breakthrough ↗

February 17, 2026

Via The Motley Fool

Frequently Asked Questions

Is Insmed Incorporated - Common Stock publicly traded?

Yes, Insmed Incorporated - Common Stock is publicly traded.

What exchange does Insmed Incorporated - Common Stock trade on?

Insmed Incorporated - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Insmed Incorporated - Common Stock?

The ticker symbol for Insmed Incorporated - Common Stock is INSM on the Nasdaq Stock Market

What is the current price of Insmed Incorporated - Common Stock?

The current price of Insmed Incorporated - Common Stock is 102.15

When was Insmed Incorporated - Common Stock last traded?

The last trade of Insmed Incorporated - Common Stock was at 06/05/26 09:42 AM ET

What is the market capitalization of Insmed Incorporated - Common Stock?

The market capitalization of Insmed Incorporated - Common Stock is 11.77B

How many shares of Insmed Incorporated - Common Stock are outstanding?

Insmed Incorporated - Common Stock has 12B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.